Stoke Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,178 | 0.0% | 37,127 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 754 | 0.0% | 32,070 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 364 | 0.0% | 32,068 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 213 | 0.0% | 32,068 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 354 | 0.0% | 32,068 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 339 | 0.0% | 27,600 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 447 | 0.0% | 33,087 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 38 | 0.0% | 2,803 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 24 | 0.0% | 4,540 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 93 | 0.0% | 23,651 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 283 | 0.0% | 26,662 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 185 | 0.0% | 22,164 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 212 | 0.0% | 22,919 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 287 | 0.0% | 22,350 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 291 | 0.0% | 22,056 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 404 | 0.0% | 19,181 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 511 | 0.0% | 21,313 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 530 | 0.0% | 20,830 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 887 | 0.0% | 26,337 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 795 | 0.0% | 20,463 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,162 | 0.0% | 18,764 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 617 | 0.0% | 18,420 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 439 | 0.0% | 18,420 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 592 | 0.0% | 25,853 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 404 | 0.0% | 14,264 | 12/31/2019 |